Filter
472
Filtered Results: 472
Text search:
pyrazinamide
Featured
Recommendations
70
New Publications
131
Language
Document type
No document type
319
Guidelines
78
Manuals
26
Studies & Reports
21
Training Material
12
Strategic & Response Plan
7
Fact sheets
7
Situation Updates
2
Countries / Regions
Western and Central Europe
25
India
25
Nepal
14
Eastern Europe
12
Kenya
11
Argentina
11
Senegal
8
Peru
8
Tanzania
8
Bangladesh
8
Ethiopia
8
South Africa
7
Uganda
7
Malawi
6
Germany
6
Paraguay
6
Indonesia
6
Ukraine
5
Bolivia
5
Zambia
5
Colombia
4
Nigeria
4
Philippines
4
Mozambique
4
Cambodia
4
Brazil
4
Russia
4
Namibia
4
El Salvador
3
Lesotho
3
Ghana
3
Rwanda
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
3
Botswana
3
Ecuador
3
Myanmar / Burma
3
Eswatini/ Swaziland
3
Benin
2
Cameroon
2
Burkina Faso
2
Zimbabwe
2
Haiti
2
Tajikistan
1
Switzerland
1
Gambia
1
Chile
1
Malaysia
1
Asia
1
Venezuela
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Uruguay
1
Romania
1
Central African Republic
1
Chad
1
Libya
1
Bhutan
1
Liberia
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
129
TB
60
Drugs & Medical Equipment
38
Guidelines
34
Studies & Reports
19
Pediatrics
15
Capacity Building
13
Women & Child Health
9
Paediatrics
8
Policies
7
Demograhic Health Surveys DHS
5
Community Health
5
Disease Prevention & Control
5
Bacteriology
4
COVID-19
3
Countries
3
Statistics
3
HIV & STI
3
Clinical Guidelines
2
Communicable Diseases
2
NTDs & Others
2
Communicable Diseases
1
Dental & Eye Care
1
Clinical Training
1
Public Health
1
Under-5 nutrition
1
Child Health
1
Buruli Ulcer
1
Diabetes
1
Dermatology
1
Maternal & Child Health
1
Public Health
1
Vaccine-preventable Diseases
1
Information, Education and Communication (IEC)
1
Quality Control & Assurance
1
Reproductive Health
1
Toolboxes
Drug resistant TB
43
Adults
30
Children
26
Detection & Diagnosis
24
Essential Medicines & Devices Lists
22
Training
18
Prevention & Control
12
Childhood TB
10
General
10
TB/HIV Coinfection
10
Argentina
9
TB & Prisoners
9
Peru
8
Other Countries
8
Research & Access
8
TB
8
Essential Medicines
6
Romania
6
Tuberculosis
6
Germany
6
Clinical Aspects
5
Children & Adolescents
5
IEC Materials
5
Brazil
5
HIV &TB
5
Disease Prevention & Control
5
Nutrition
5
TB & Drug Abuse
4
Moldova
4
Treatment & Prevention
4
Communication & Training
4
South-east Asia Region
4
Kenya
4
Policies & Strategies
3
Vaccines & Immunization
3
Ukraine
3
Laboratory
3
TB & Other Vulnerable Populations
3
Ethiopia
3
Essential List
3
Hospital Readiness/Essential Health Services
3
Colombia
3
El Salvador
3
Falsified & Substandard
3
Malawi
3
Clinical Guidelines
3
Eastern Europe & Central Asia
3
Country specific
2
South Africa
2
Eastern Mediterranean Region
2
Namibia
2
TB
2
Mozambique
2
Country Guidelines
2
Reports
2
Country Specific
2
TB/HIV
2
TB/COVID-19
2
Latin America
2
Ecuador
2
Prices and Patents
2
Model Formulary
2
Pharmacy Practice
2
Policies and guidelines
2
Uganda
2
HIV and coinfection
2
Kazakhstan
2
Western & Central Europe
2
AmR (Region of Americas)
2
Epidemiology
2
Biosafety
1
Azerbaijan
1
Clinical Aspects, Treatment & Prevention
1
Policies & Strategies
1
Clinical Guidelines
1
Pediatrics
1
Opportunistic Infections
1
Prevention Guidelines
1
National Policies
1
Social Worker
1
Eastern Europe
1
HIV
1
Global
1
People who injecting Drugs
1
Rwanda
1
Prophylaxis
1
Vaccination
1
Health & Refugee
1
Georgia
1
Drug resistance
1
Workplace
1
Belarus
1
HIV / AIDS
1
Medical professionals
1
Russia
1
DR Congo
1
Clinical Guidelines
1
Country specific documents
1
Essential Medicines & Medical Devices
1
Community Health Workers CHW
1
Advocacy & Communication
1
Chile
1
Rational use of Medicine
1
Health Worker
1
General
1
Botswana
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
Ghana
1
Community Worker
1
TB/HIV Global
1
Lesotho
1
Latin America & the Carribean
1
Clinical Guidelines
1
Nigeria
1
Tajikistan
1
Antiretroviral Treatment ART
1
Preparedness & Prevention
1
Case Definitions
1
Prisoners
1
Meningitis & Encephalitis
1
Volunteers
1
SEAR (South-east Asia Region)
1
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP)...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
International Journal of Drug Policy 24 (2013) e91-98
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...
Diagnosis and Treatment Outcomes of Tuberculosis in Relation to Gender and HIV Status in South Benin
Journal of Tuberculosis Research, 2017, 5, 189-200
Background: In Benin, little is known about the influence of both gender and
HIV-status on diagnostic patterns and treatment outcomes of Tuberculosis
(TB) patients. Objective: To assess whether differences in gender and HIV
status affect diagn...
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
Over 2 million children worldwide are living with HIV infection and 95% reside in sub-Saharan Africa with the majority infected through mother-to-child transmission. Infected children have a high mortality with 50% dying by 2 years of age. Their clinical presentation includes common childhood infect...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
Accessed 25th March 2015
National Tuberclosis and
Leprosy Programme (NTLP)
